liquiritigenin has been researched along with Liver Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jung, EH; Kim, SC; Kim, YW; Lee, JH | 1 |
1 other study(ies) available for liquiritigenin and Liver Dysfunction
Article | Year |
---|---|
AMPK activation by liquiritigenin inhibited oxidative hepatic injury and mitochondrial dysfunction induced by nutrition deprivation as mediated with induction of farnesoid X receptor.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Line; Culture Media, Serum-Free; Enzyme Activation; Flavanones; Hep G2 Cells; Hepatocytes; Humans; Liver; Liver Diseases; Male; Malnutrition; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Oxidative Stress; Rats; Receptors, Cytoplasmic and Nuclear | 2017 |